2021年欧洲心力衰竭指南:个体化治疗的案例

European cardiology Pub Date : 2022-01-28 eCollection Date: 2022-02-01 DOI:10.15420/ecr.2021.57

Nesan Shanmugam

{"title":"2021年欧洲心力衰竭指南:个体化治疗的案例","authors":"Nesan Shanmugam","doi":"10.15420/ecr.2021.57","DOIUrl":null,"url":null,"abstract":"© RADCLIFFE CARDIOLOGY 2022 www.ECRjournal.com The field of heart failure (HF) has seen the development of unparalleled evidence-based therapies over the last 30 years, with continuous improvement in survival and quality of life for our patients. It is unquestionably an exciting time to be considering or pursuing HF as a subspecialty. Pivotal to and underpinning these advances is the guidance provided by international HF guidelines, particularly from the European Society of Cardiology (ESC). The new 2021 ESC HF guidelines have a total of 41 new and 15 modified recommendations from the 2016 document.1","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e01"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/cb/ecr-17-e01.PMC8819603.pdf","citationCount":"0","resultStr":"{\"title\":\"The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics.\",\"authors\":\"Nesan Shanmugam\",\"doi\":\"10.15420/ecr.2021.57\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"© RADCLIFFE CARDIOLOGY 2022 www.ECRjournal.com The field of heart failure (HF) has seen the development of unparalleled evidence-based therapies over the last 30 years, with continuous improvement in survival and quality of life for our patients. It is unquestionably an exciting time to be considering or pursuing HF as a subspecialty. Pivotal to and underpinning these advances is the guidance provided by international HF guidelines, particularly from the European Society of Cardiology (ESC). The new 2021 ESC HF guidelines have a total of 41 new and 15 modified recommendations from the 2016 document.1\",\"PeriodicalId\":93994,\"journal\":{\"name\":\"European cardiology\",\"volume\":\" \",\"pages\":\"e01\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/cb/ecr-17-e01.PMC8819603.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15420/ecr.2021.57\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/ecr.2021.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/2/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics.

© RADCLIFFE CARDIOLOGY 2022 www.ECRjournal.com The field of heart failure (HF) has seen the development of unparalleled evidence-based therapies over the last 30 years, with continuous improvement in survival and quality of life for our patients. It is unquestionably an exciting time to be considering or pursuing HF as a subspecialty. Pivotal to and underpinning these advances is the guidance provided by international HF guidelines, particularly from the European Society of Cardiology (ESC). The new 2021 ESC HF guidelines have a total of 41 new and 15 modified recommendations from the 2016 document.1

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European cardiology

自引率

0.00%

发文量

期刊最新文献

Managing Obesity in Individuals with Cardiovascular Disease: Are We Missing the Obvious? The Biological Mechanisms of Frailty: Focusing on Cellular Senescence. Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients. ANGPTL3 Gene Editing: Promise and Prudence. No DECAF Coffee for Me, Please!